VR Logo

Unrated

Axis Healthcare ETF


Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund -- -0.49 -2.09 -0.83 1.76 -- -- -- -- -- --
S&P BSE Healthcare TRI -- -0.46 -1.88 -0.29 1.98 -- -- -- -- -- --
Equity: Sectoral-Pharma -- -0.31 -1.34 0.29 3.37 -- -- -- -- -- --
Rank within category -- 9 12 12 9 -- -- -- -- -- --
Number of funds in category 9 12 12 12 11 9 9 6 4 3 3

As on 28-Sep-2021

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
Axis Healthcare ETF
Unrated
May-21 -- -- -- 0.22 21
Nippon India Pharma Fund
Unrated
Jun-04 35.35 24.52 15.68 1.95 5,667
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 31.77 26.35 -- 2.00 3,158
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 31.24 22.75 9.31 2.08 2,048
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 34.90 29.97 -- 2.10 1,901

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 4.61 26-Aug-2021 - 02-Sep-2021 -3.29 22-Jul-2021 - 29-Jul-2021
Month 6.03 18-Jun-2021 - 19-Jul-2021 -2.02 23-Jul-2021 - 23-Aug-2021
Quarter 8.98 04-Jun-2021 - 03-Sep-2021 4.28 24-May-2021 - 23-Aug-2021
Year -- - -- -

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 20.04 21.96 0.73 1.60 -- --
Equity: Sectoral-Pharma* 23.75 19.96 0.99 2.23 0.89 5.48
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-Aug-2021

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 20
Top 10 Stocks (%) 77.58
Top 5 Stocks (%) 57.90
Top 3 Sectors (%) 99.82
Portfolio P/B Ratio 5.46
Portfolio P/E Ratio 33.15

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 68,915 58,801
Giant (%) 16.21 15.06
Large (%) 50.60 45.41
Mid (%) 33.19 32.94
Small (%) -- 8.56
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
down Sun Pharmaceutical Industries Healthcare 31.16 16.18 14.35 16.18
down Divi's Laboratories Healthcare 61.96 12.44 10.94 12.44
down Dr. Reddy's Lab Healthcare 46.41 13.17 10.77 10.77
down Apollo Hospitals Healthcare 421.77 9.43 6.58 9.43
down Cipla Healthcare 30.88 9.86 9.05 9.08
down Laurus Labs Healthcare 30.18 5.19 4.09 4.92
down Lupin Healthcare 26.08 6.01 4.34 4.34
down Aurobindo Pharma Healthcare 7.98 5.80 3.85 3.85
down Ipca Laboratories Healthcare 29.86 3.33 2.74 3.33
down Alkem Laboratories Healthcare 28.92 3.24 2.56 3.24
down Biocon Healthcare 64.34 3.55 3.08 3.08
down Torrent Pharmaceuticals Healthcare 41.58 2.92 2.73 2.88
down Fortis Healthcare Healthcare -- 2.85 2.44 2.85
down Cadila Healthcare Healthcare 24.60 3.25 2.67 2.67
down Dr. Lal Pathlabs Healthcare 77.04 2.47 1.91 2.47
down Abbott India Healthcare 63.24 1.96 1.70 1.90
down Pfizer Healthcare 44.94 1.77 1.63 1.69
down Natco Pharma Healthcare 41.51 2.07 1.66 1.66
down Sanofi India Healthcare 31.25 1.55 1.39 1.55
down Glenmark Pharma. Healthcare 13.72 1.92 1.49 1.49

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Aug-2021

Fund Manager

— Jinesh Gopani since 30-Apr-2021

Education: Mr. Gopani is a B. Com (H) and MMS from Bharati Vidyapeeth Institute of Management Studies and Research.

Experience: Prior to joining Axis AMC he has worked with Birla Sun Life AMC, Voyager India Capital Pvt. Ltd., Emkay Shares & Stock Brokers Limited and Net worth Stock Broking Limited.

Interviews:

Funds Managed:


-0.49%

Change from previous, NAV as on 28-Sep-2021

Growth: ₹ 88.5868


Investment Strategy

The scheme seeks to provide returns before expenses that closely correspond to the total returns of the NIFTY Healthcare Index subject to tracking errors.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) --
Minimum SIP Investment (₹) --
Minimum No of Cheques --
Minimum Withdrawal (₹) --
Minimum Balance (₹) --
Lock-in Period Not Applicable
Exit Load 0

Basic Details

Fund House: Axis Mutual Fund
Launch Date: 17-May-2021
Return Since Launch: 5.60%
Benchmark: NIFTY Healthcare TRI.
Riskometer: Very High
Type: Open-ended
Assets: ₹ 21 Cr (As on 31-Aug-2021)
Expense: 0.22% (As on 31-Aug-2021)
Risk Grade: --
Return Grade: --
Turnover: --

Contact Information

AMC: Axis Asset Management Company Ltd.

Address: "Axis House" - 1st Floor, C-2 - Wadia International Centre, Pandurang Budhkar Marg , Worli, Mumbai - 400025

Phone: 022-24255161

Fax: 022-43255199

Email: [email protected] / [email protected]

Website: http://www.axismf.com

Registrar & Transfer Agent: KFin Technologies Pvt Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Viewpoint

The Case for ESG Investing

DateThursday, 30-Sep-2021
Time04:00 PM - 04:30 PM